● Independent ● Community Verified ●

Dosage & Reconstitution Guide

HGH 191AA Dosage & Reconstitution Guide

A clear educational guide covering HGH 191AA reconstitution, unit conversions, common protocol examples, supplies, storage, injection technique, growth hormone research notes and safety considerations.

Important: This content is for educational and research reference only. It is not medical advice, dosing advice or a treatment recommendation. Peptide Hub Australia does not sell peptides and does not recommend human use.

Quickstart Highlights

  • Compound: HGH 191AA, also known as recombinant human growth hormone or somatropin
  • Common vial size: 10 IU, equal to approximately 3.33mg
  • Example reconstitution: 3.0mL bacteriostatic water
  • Resulting concentration: approximately 1.11mg/mL, or 1,111mcg/mL
  • U-100 syringe maths: 1 unit = 0.01mL = approximately 11.1mcg
  • Common conservative range discussed: 150mcg to 500mcg daily
  • Advanced research range discussed: 1,000mcg to 2,000mcg daily
  • Storage after mixing: refrigerate at 2-8°C and avoid repeated freeze-thaw cycles

What is HGH 191AA?

HGH 191AA refers to recombinant human growth hormone made with the same 191 amino acid sequence as naturally occurring human growth hormone. It is commonly discussed under names such as HGH, GH and somatropin.

In research and clinical discussions, HGH is most often associated with body composition, lean body mass, fat metabolism, tissue repair, IGF-1 signalling and growth-hormone-deficiency treatment contexts.

HGH 191AA Reconstitution Example

The example below is based on a common 10 IU HGH 191AA vial, equal to approximately 3.33mg, mixed with 3.0mL bacteriostatic water.

Reconstitution Maths

10 IU = approximately 3.33mg
3.33mg ÷ 3.0mL = approximately 1.11mg/mL
1.11mg/mL = approximately 1,111mcg/mL
1 unit on a U-100 syringe = 0.01mL
1,111mcg/mL × 0.01mL = approximately 11.1mcg per unit

HGH 191AA Unit Conversion Table

This table uses the example concentration of a 10 IU / 3.33mg HGH vial mixed with 3.0mL bacteriostatic water.

Target Amount U-100 Units mL
200mcg 18 units 0.18mL
300mcg 27 units 0.27mL
500mcg 45 units 0.45mL
1,000mcg / 1mg 90 units 0.90mL

Standard Gradual Titration Example

This example uses a 10 IU / 3.33mg vial reconstituted with 3.0mL bacteriostatic water, giving a concentration of approximately 1.11mg/mL.

Week Daily Amount U-100 Units mL
Week 1200mcg18 units0.18mL
Week 2300mcg27 units0.27mL
Week 3400mcg36 units0.36mL
Week 4500mcg45 units0.45mL
Week 5600mcg54 units0.54mL
Week 6700mcg63 units0.63mL
Week 7800mcg72 units0.72mL
Week 8900mcg81 units0.81mL
Research note: This is a research-style measurement example only. HGH 191AA is a growth hormone compound with significant endocrine effects, and this page should not be treated as personal dosing advice or an instruction to use it.

Extended 12-Week Research Example

Some advanced research-style examples discuss higher daily amounts after week 8. These higher amounts may carry a greater risk of side effects and should be discussed carefully.

Week Daily Amount U-100 Units mL
Week 91,000mcg90 units0.90mL
Week 101,100mcg99 units0.99mL
Week 111,200mcg108 units1.08mL
Week 121,300mcg117 units1.17mL

Frequency and Timing Notes

HGH 191AA is commonly discussed as a once-daily subcutaneous compound in research-style protocols. Evening or bedtime timing is often discussed because it is intended to align more closely with natural growth hormone secretion patterns.

Higher-dose examples may produce more noticeable physiological effects, but they also increase the potential for side effects such as fluid retention, joint discomfort and glucose-related changes.

Reconstitution Steps

  1. Confirm the vial size before calculating concentration.
  2. Draw 3.0mL bacteriostatic water using sterile technique.
  3. Inject the bacteriostatic water slowly down the inside wall of the vial.
  4. Avoid blasting the powder directly and avoid creating foam.
  5. Gently swirl or roll the vial until the powder fully dissolves.
  6. Do not shake aggressively, as HGH is a protein-based compound.
  7. Label the vial with the reconstitution date and concentration.
  8. Store the reconstituted vial in the refrigerator at 2-8°C, protected from light.

Supplies Needed

The following example is based on an 8-16 week daily research-style protocol using 10 IU / 3.33mg HGH 191AA vials.

HGH 191AA Vials

  • 8-week example: approximately 10 vials.
  • 12-week example: approximately 19 vials.
  • 16-week example: approximately 32 vials.
  • Vial size used in this guide: 10 IU / approximately 3.33mg.

Insulin Syringes

  • Daily example: 7 syringes per week.
  • 8 weeks: approximately 56 syringes.
  • 12 weeks: approximately 84 syringes.
  • 16 weeks: approximately 112 syringes.

Bacteriostatic Water

  • Per 10 IU vial: 3.0mL bacteriostatic water.
  • 8-week example: 10 vials × 3.0mL = 30mL total, so around 3 × 10mL bottles.
  • 12-week example: 19 vials × 3.0mL = 57mL total, so around 6 × 10mL bottles.
  • 16-week example: 32 vials × 3.0mL = 96mL total, so around 10 × 10mL bottles.

Alcohol Swabs

  • Per administration: one swab for the vial stopper and one for the injection site.
  • Per week: approximately 14 swabs based on daily administration.
  • 8 weeks: around 112 swabs, so 2 × 100-count boxes may be needed.
  • 12 weeks: around 168 swabs, so 2 × 100-count boxes may be needed.
  • 16 weeks: around 224 swabs, so 3 × 100-count boxes may be needed.

Protocol Overview

  • Goal discussed in research: body composition, lean mass, adipose tissue reduction and metabolic function.
  • Schedule example: once-daily subcutaneous administration.
  • Conservative range discussed: 150-500mcg daily.
  • Advanced research range discussed: 1,000-2,000mcg daily.
  • Example reconstitution: 3.0mL bacteriostatic water per 10 IU / 3.33mg vial.
  • Concentration: approximately 1.11mg/mL.
  • Cycle length: 8-12 weeks is commonly discussed, with some advanced examples extending to 16 weeks.
  • Timing: evening or bedtime timing is commonly discussed.

Example Dosing Protocol

  • Gradual example: start at 200mcg daily and increase by around 100mcg each week.
  • Conservative target: 400-900mcg daily by weeks 4-8 in some examples.
  • Advanced target: 1,000-1,300mcg daily by weeks 9-12 in some higher-dose research examples.
  • Frequency: once daily in most research-style examples.
  • Practical note: at this dilution, each U-100 unit equals approximately 11.1mcg.

How HGH 191AA Works

HGH 191AA is recombinant human growth hormone that is structurally identical to endogenous growth hormone secreted by the pituitary gland. It is commonly discussed for its relationship with IGF-1 production, protein synthesis, lipolysis and body composition changes.

In clinical research, growth hormone administration has been associated with changes in lean body mass, fat mass and metabolic markers in specific studied populations. However, these effects vary depending on dose, duration, baseline hormone status and individual response.

HGH is not an oral compound. It is protein-based and would be broken down in the digestive system, which is why research and clinical contexts discuss injectable administration.

Potential Benefits Discussed in Research

  • Lean body mass research
  • Adipose tissue reduction discussions
  • Fat oxidation and lipolysis research
  • IGF-1 signalling
  • Protein synthesis pathways
  • Body composition research
  • Growth hormone deficiency treatment contexts
  • Metabolic function research
  • Tissue repair and recovery discussions

Reported Side Effects and Limitations

HGH 191AA can have significant systemic effects. Side effects are commonly described as dose-dependent, with higher-dose examples carrying a greater risk profile.

  • Injection-site redness or irritation
  • Fluid retention
  • Peripheral oedema
  • Joint discomfort or arthralgia
  • Possible glucose metabolism changes
  • Lipoatrophy risk if injection sites are not rotated properly
  • Unknown outcomes outside studied or medically supervised settings
Important safety note: HGH 191AA should not be treated casually. It should not be marketed as a guaranteed fat-loss, anti-ageing, performance or muscle-building solution. Any real-world use belongs under qualified medical supervision.

Storage Instructions

  • Lyophilised powder: store frozen at around -20°C for longer-term storage, protected from heat, moisture and light.
  • After reconstitution: refrigerate at 2-8°C.
  • Use window: commonly discussed as several weeks after reconstitution when stored properly.
  • Avoid: heat, sunlight, contamination and repeated freeze-thaw cycles.
  • Do not shake: HGH is a protein-based compound and should be handled gently.
  • Practical note: allow cold vials to reach room temperature before opening to reduce condensation exposure.

Injection Technique Notes

This section is general educational information only. It is not personal injection instruction.

  • Use a new sterile insulin syringe for each administration.
  • Clean the vial stopper and skin with alcohol and allow both to dry.
  • Common subcutaneous sites discussed include abdomen, thighs and upper arms.
  • Rotate injection sites to reduce irritation and lipoatrophy risk.
  • Pinch a skinfold and insert into subcutaneous tissue at an appropriate angle.
  • Do not aspirate for subcutaneous injections.
  • Inject slowly and steadily.
  • Wait a few seconds before withdrawing the needle.
  • Do not rub the site afterwards.
  • Dispose of used sharps safely in a sharps container.

Lifestyle Factors That May Matter

  • Protein intake: adequate protein is commonly discussed alongside anabolic and tissue-repair pathways.
  • Resistance training: progressive overload may support lean-mass research goals.
  • Cardio: cardiovascular activity may support metabolic adaptation and fat oxidation.
  • Sleep: sleep quality is closely connected with endogenous growth hormone rhythms.
  • Stress management: chronic stress may interfere with hormone signalling and recovery.
  • Hydration: adequate hydration may matter, particularly where fluid retention is being monitored.
  • Tracking: documenting amount, date, injection site and observed effects can make research observations easier to review.

Use the Peptide Calculator

If your vial size, water volume or target amount is different, use the Peptide Hub Australia calculator to work out concentration, mL and syringe units.

Calculate HGH 191AA Units

Enter your vial size, BAC water amount and target amount to calculate concentration and syringe units.

Open Peptide Calculator

Where to Compare HGH 191AA Suppliers

Peptide Hub Australia does not sell HGH 191AA or any other peptides. We compare Australian peptide vendors, package audits, pricing and supplier information to help users review the market more clearly.

Frequently Asked Questions

How much BAC water do you add to a 10 IU HGH 191AA vial?

A common educational example is 3.0mL bacteriostatic water added to a 10 IU / 3.33mg vial, creating a concentration of approximately 1.11mg/mL.

How many units is 200mcg of HGH 191AA?

If a 10 IU vial is mixed with 3.0mL, 200mcg is approximately 18 units on a U-100 insulin syringe, equal to around 0.18mL.

How many units is 500mcg of HGH 191AA?

If a 10 IU vial is mixed with 3.0mL, 500mcg is approximately 45 units on a U-100 insulin syringe, equal to around 0.45mL.

How many units is 1mg of HGH 191AA?

If a 10 IU vial is mixed with 3.0mL, 1mg, or 1,000mcg, is approximately 90 units on a U-100 insulin syringe, equal to around 0.90mL.

How long does one 10 IU HGH vial last?

This depends on the research amount. At 200mcg daily, one 10 IU / 3.33mg vial lasts around 16 days. At 500mcg daily, it lasts around 6-7 days.

Is HGH 191AA the same as somatropin?

HGH 191AA is commonly used to describe recombinant human growth hormone with the 191 amino acid sequence. Somatropin is the pharmaceutical name commonly used for recombinant human growth hormone.

Is HGH taken orally?

No. HGH is a protein-based compound and would be broken down in the digestive system. Research and clinical contexts discuss injectable administration.

Is HGH proven to improve athletic performance?

HGH has been associated with lean body mass changes in some research, but systematic reviews in healthy athletes have not shown clear improvements in strength or exercise performance.

Is this a personal dosing recommendation?

No. This page is an educational reconstitution and measurement guide only. It is not medical advice or a personal protocol.

Related Resources

Leave a Reply

Your email address will not be published. Required fields are marked *

New Providers
Australian Research Peptides Review (2026)

Australian Research Peptides

Supplier Janoshik Reports Competitive Pricing 23+ Products Listed

Apex Lab Aus Review (2026)

Apex Lab Aus

Highly Competitive 10-Vial Bulk Packs Australian Retail Stock & Dispatch Testing Available on Request

NuVion Health Review (2026)

NuVion Health

11 Verifiable Janoshik Reports Australian Stock & Dispatch 30+ Research Products

Peptide Planet Review (2026)

Peptide Planet

Supplier BTLabs Reports Competitive Pricing 21+ Products Listed

PhaseOne Australia Review (2026)

PhaseOne AUS

Supplier Janoshik Reports Competitive Pricing 23+ Products Listed

Recent News